| Literature DB >> 32605205 |
Hironori Kaminaka1, Chihiro Miura1, Yukiko Isowa1, Takaya Tominaga2, Mamu Gonnami3, Mayumi Egusa1, Shinsuke Ifuku4.
Abstract
Chitin, an N-acetylglucosamine polymer, is well-known to have unique biological functions, such as growth promotion and disease resistance induction in plants. Chitin has been expectedly used for improving crop yield using its functions; however, chitin derivatives, such as chitin oligosaccharide (CO) and chitosan, are widely used instead since chitin is difficult to handle because of its insolubility. Chitin nanofiber (CNF), produced from chitin through nanofibrillation, retains its polymeric structure and can be dispersed uniformly even in water. Here, the effects of CO and CNF on plant responses were directly compared in soybeans (Glycine max) to define the most effective method to produce chitin derivatives for plant response induction. The growth promotion of aerial parts was observed only in CNF-treated plants. The transcriptome analysis showed that the number of differentially expressed genes (DEGs) in CNF-treated soybeans was higher than in CO-treated soybeans. Notably, the expression patterns of DEGs were mostly similar but were strongly induced by CNF treatment as compared with the CO group. These results reveal that CNF can induce stronger plant response to chitin than CO in soybeans, suggesting nanofibrillation, rather than oligomerization, as a more effective method to produce chitin derivatives for plant response induction.Entities:
Keywords: Glycine max; chitin; chitin nanofiber; growth promotion; nanofibrillation; transcriptome
Year: 2020 PMID: 32605205 PMCID: PMC7411678 DOI: 10.3390/plants9070810
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Figure 1The effects of chitin supplementation to soils on soybean plant growth. The soybean plants were grown on soil mixed with equal volume of 0.01% (w/v) chitin oligosaccharide (CO) solution or chitin nanofiber (CNF) dispersion for four weeks and then harvested for measurement of length (a) and dry weight (b) of shoots and roots. Data are shown as mean and SE (n = 4). Different letter types (uppercase and lower case) denote significant differences (Tukey’s HSD test, p < 0.05). Data are representative of three independent biological experiments, showing similar results.
Significantly differentially expressed genes (DEGs) in chitin oligosaccharides (CO) and/or chitin nanofiber (CNF)-treated soybean plants.
| Gene ID | Description | CO/Control | CNF/Control | ||
|---|---|---|---|---|---|
| log2FC | FDR a | log2FC | FDR a | ||
| CO only | |||||
| GLYMA_11G176200 | Uncharacterized protein | 1.76 | 2.74 | −0.31 | 1.00 |
| GLYMA_11G070500 | Isoflavone reductase, NmrA domain-containing protein | 1.36 | 1.98 | 0.67 | 9.43 |
| GLYMA_08G277000 | TRANSKETOLASE_1 domain-containing protein | 1.26 | 1.17 | 0.88 | 3.36 |
| GLYMA_08G338200 | Glycosyltransferase (EC 2.4.1.-) | 1.09 | 3.04 | 0.62 | 1.00 |
| CO and CNF | |||||
| GLYMA_04G020700 | Syringolide-induced protein 14-1-1 | 2.22 | 1.47 | 2.34 | 7.60 |
| GLYMA_10G272000 | Uncharacterized protein | 1.74 | 1.99 | 2.00 | 4.01 |
| GLYMA_05G136100 | Glutamate decarboxylase (EC 4.1.1.15) | 1.63 | 2.30 | 2.11 | 6.65 |
| GLYMA_08G109400 | Chalcone synthase 1 (EC 2.3.1.74) | 1.30 | 7.11 | 1.45 | 1.79 |
| GLYMA_10G295200 | C2H2-type domain-containing protein | 1.25 | 1.50 | 1.47 | 3.87 |
| GLYMA_02G265900 | Uncharacterized protein | 1.24 | 5.89 | 1.57 | 2.97 |
| CNF only | |||||
| GLYMA_18G061000 | PPM-type phosphatase domain-containing protein | 2.28 | 2.42 | 2.98 | 3.85 |
| GLYMA_01G236200 | Uncharacterized protein | 1.61 | 1.00 | 2.59 | 3.20 |
| GLYMA_02G000800 | BHLH domain-containing protein | 2.13 | 5.36 | 2.46 | 1.51 |
| GLYMA_01G127100 | Dirigent protein | 1.91 | 6.91 | 2.42 | 5.28 |
| GLYMA_08G091400 | Glutamate decarboxylase (EC 4.1.1.15) | 1.18 | 2.42 | 1.86 | 7.46 |
| GLYMA_13G093300 | PBPe domain-containing protein | 0.96 | 5.93 | 1.76 | 1.79 |
| GLYMA_02G054900 | Uncharacterized protein | 1.06 | 1.00 | 1.76 | 1.42 |
| GLYMA_06G265500 | GRAS domain-containing protein | 1.01 | 1.47 | 1.71 | 1.37 |
| GLYMA_20G013400 | Uncharacterized protein | 1.11 | 9.36 | 1.67 | 1.82 |
| GLYMA_18G290400 | Uncharacterized protein | 1.19 | 1.00 | 1.66 | 2.68 |
| GLYMA_18G127900 | TIR-NBS-LRR type disease resistance protein | 1.14 | 5.75 | 1.65 | 1.79 |
| GLYMA_13G206700 | TPT domain-containing protein | 0.85 | 8.68 | 1.65 | 5.62 |
| GLYMA_15G052600 | Peroxidase (EC 1.11.1.7) | 0.95 | 1.00 | 1.63 | 8.57 |
| GLYMA_18G271300 | Protein kinase domain-containing protein | 0.93 | 2.41 | 1.59 | 2.18 |
| GLYMA_11G051800 | Uncharacterized protein | 1.16 | 5.82 | 1.53 | 1.49 |
| GLYMA_13G033500 | Protein kinase domain-containing protein | 0.78 | 1.00 | 1.50 | 2.55 |
| GLYMA_19G085200 | Uncharacterized protein | 1.01 | 9.23 | 1.47 | 8.31 |
| GLYMA_10G253100 | Uncharacterized protein | 1.01 | 3.80 | 1.43 | 3.85 |
| GLYMA_02G242900 | RING-type E3 ubiquitin transferase (EC 2.3.2.27) | 1.06 | 5.80 | 1.39 | 3.87 |
| GLYMA_01G238800 | MFS domain-containing protein | 0.81 | 7.33 | 1.30 | 7.50 |
| GLYMA_07G188800 | Uncharacterized protein | 0.88 | 2.42 | 1.28 | 5.87 |
| GLYMA_11G077900 | Rhodanese domain-containing protein | 0.77 | 7.06 | 1.27 | 1.42 |
| GLYMA_01G225100 | PPM-type phosphatase domain-containing protein | 0.28 | 1.00 | 1.23 | 3.46 |
| GLYMA_05G015400 | Phospholipid-transporting ATPase (EC 7.6.2.1) | 0.85 | 2.42 | 1.20 | 3.20 |
| GLYMA_20G236200 | Uncharacterized protein | 0.68 | 1.00 | 1.19 | 4.31 |
| GLYMA_05G132900 | Uncharacterized protein | 0.55 | 1.00 | 1.12 | 3.87 |
| GLYMA_10G185200 | Zeta_toxin domain-containing protein | 0.77 | 5.92 | 1.12 | 3.87 |
| GLYMA_13G133100 | Uncharacterized protein | 0.79 | 5.47 | 1.08 | 4.80 |
| GLYMA_13G208000 | Peptidase A1 domain-containing protein | 0.41 | 1.00 | 1.00 | 1.42 |
| GLYMA_02G097400 | Protein kinase domain-containing protein | −0.42 | 1.00 | −1.28 | 2.68 |
| GLYMA_01G081300 | Uncharacterized protein | −0.50 | 1.00 | −1.28 | 1.88 |
| GLYMA_10G207000 | Uncharacterized protein | −0.35 | 1.00 | −1.38 | 1.79 |
| GLYMA_04G023700 | Uncharacterized protein | −0.61 | 1.00 | −1.43 | 1.49 |
| GLYMA_03G018800 | TCP domain-containing protein | −0.15 | 1.00 | −1.56 | 3.85 |
a False discovery rate: DEGs were determined using FDR (< 0.05).
Figure 2Differential expression analysis in chitin oligosaccharides (CO)- and chitin nanofiber (CNF)-treated soybean plants. Venn diagram (a) and clustered heatmap (b) of all differentially expressed genes.
The number of differentially expressed genes categorized by gene ontology (GO) terms in chitin nanofiber-treated soybean plants.
| GO Term | Category a | N | Genes |
|---|---|---|---|
| Drug binding | MF | 10 | GLYMA_02G097400 GLYMA_05G015400 GLYMA_05G132900 GLYMA_05G136100 GLYMA_07G188800 GLYMA_08G091400 GLYMA_10G185200 GLYMA_10G253100 GLYMA_13G033500 GLYMA_18G271300 |
| Cell periphery | CC | 9 | GLYMA_01G238800 GLYMA_02G097400 GLYMA_05G015400 GLYMA_07G188800 GLYMA_10G253100 GLYMA_13G093300 GLYMA_15G052600 GLYMA_20G013400 GLYMA_20G236200 |
| Plasma membrane | CC | 8 | GLYMA_01G238800 GLYMA_02G097400 GLYMA_05G015400 GLYMA_07G188800 GLYMA_10G253100 GLYMA_13G093300 GLYMA_20G013400 GLYMA_20G236200 |
| Transporter activity | MF | 6 | GLYMA_01G238800 GLYMA_05G015400 GLYMA_05G132900 GLYMA_13G093300 GLYMA_13G206700 GLYMA_19G085200 |
| Response to stimulus | BP | 5 | GLYMA_13G093300 GLYMA_13G133100 GLYMA_15G052600 GLYMA_18G127900 GLYMA_20G236200 |
| Localization | BP | 5 | GLYMA_01G238800 GLYMA_05G015400 GLYMA_05G132900 GLYMA_13G206700 GLYMA_19G085200 |
| Establishment of localization | BP | 5 | GLYMA_01G238800 GLYMA_05G015400 GLYMA_05G132900 GLYMA_13G206700 GLYMA_19G085200 |
| Transmembrane transporter activity | MF | 5 | GLYMA_01G238800 GLYMA_05G132900 GLYMA_13G093300 GLYMA_13G206700 GLYMA_19G085200 |
| Catabolic process | BP | 4 | GLYMA_05G136100 GLYMA_08G091400 GLYMA_13G208000 GLYMA_15G052600 |
| Cellular response to stimulus | BP | 4 | GLYMA_13G093300 GLYMA_15G052600 GLYMA_18G127900 GLYMA_20G236200 |
| Cofactor binding | MF | 4 | GLYMA_05G136100 GLYMA_08G091400 GLYMA_11G051800 GLYMA_15G052600 |
| Regulation of metabolic process | BP | 3 | GLYMA_03G018800 GLYMA_06G265500 GLYMA_10G295200 |
| Response to chemical | BP | 3 | GLYMA_13G133100 GLYMA_15G052600 GLYMA_20G236200 |
| DNA-binding transcription factor activity | MF | 3 | GLYMA_03G018800 GLYMA_06G265500 GLYMA_10G295200 |
| Oxidoreductase activity | MF | 3 | GLYMA_11G051800 GLYMA_15G052600 GLYMA_20G236200 |
| Signaling | BP | 2 | GLYMA_13G093300 GLYMA_18G127900 |
| Detoxification | BP | 2 | GLYMA_15G052600 GLYMA_20G236200 |
| Cellular detoxification | BP | 2 | GLYMA_15G052600 GLYMA_20G236200 |
| Extracellular region | CC | 2 | GLYMA_01G127100 GLYMA_15G052600 |
| Cell-cell junction | CC | 2 | GLYMA_02G097400 GLYMA_15G052600 |
| Endomembrane system | CC | 2 | GLYMA_05G015400 GLYMA_13G206700 |
| Cell junction | CC | 2 | GLYMA_02G097400 GLYMA_15G052600 |
| Symplast | CC | 2 | GLYMA_02G097400 GLYMA_15G052600 |
| Peroxidase activity | MF | 2 | GLYMA_15G052600 GLYMA_20G236200 |
| Antioxidant activity | MF | 2 | GLYMA_15G052600 GLYMA_20G236200 |
| Lyase activity | MF | 2 | GLYMA_05G136100 GLYMA_08G091400 |
| Carbohydrate binding | MF | 2 | GLYMA_01G081300 GLYMA_13G033500 |
a BP: Biological Process, CC: Cellular Component, MF: Molecular Function.
Gene ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of differentially expressed genes in chitin nanofiber-treated soybean plants.
| Functional Category (GO Category a or KEGG Pathway) | Genes in List | Total Genes | Enrichment FDR b |
|---|---|---|---|
| Glutamate catabolic process (BP) | 2 | 10 | 1.68 |
| Glutamate decarboxylase activity (MF) | 2 | 10 | 1.68 |
| Dicarboxylic acid catabolic process (BP) | 2 | 13 | 1.94 |
| Taurine and hypotaurine metabolism (KEGG) | 2 | 29 | 6.43 |
| Glutamine family amino acid catabolic process (BP) | 2 | 30 | 6.43 |
| Butanoate metabolism (KEGG) | 2 | 33 | 6.50 |
| Glutamate metabolic process (BP) | 2 | 37 | 7.01 |
| Plasma membrane (CC) | 8 | 2728 | 9.11 |
| Cell periphery (CC) | 9 | 3371 | 9.11 |
| MAPK signaling pathway (KEGG) | 3 | 230 | 9.11 |
| Alanine, aspartate and glutamate metabolism (KEGG) | 2 | 73 | 1.73 |
| Beta-Alanine metabolism (KEGG) | 2 | 81 | 1.95 |
| Drug binding (MF) | 10 | 4868 | 2.12 |
| Alpha-amino acid catabolic process (BP) | 2 | 110 | 3.05 |
| Carboxy-lyase activity (MF) | 2 | 119 | 3.17 |
| Cellular amino acid catabolic process (BP) | 2 | 120 | 3.17 |
| Organophosphate ester transport (BP) | 2 | 130 | 3.23 |
| Carbohydrate transmembrane transport (BP) | 2 | 139 | 3.23 |
| Dicarboxylic acid metabolic process (BP) | 2 | 142 | 3.23 |
| Magnesium-dependent protein serine/threonine phosphatase activity (MF) | 2 | 134 | 3.23 |
| Calcium ion binding (MF) | 3 | 474 | 3.23 |
| Glutamine family amino acid metabolic process (BP) | 2 | 137 | 3.23 |
| Metal ion binding (MF) | 9 | 4694 | 3.35 |
| Carbohydrate transmembrane transporter activity (MF) | 2 | 156 | 3.38 |
| Cation binding (MF) | 9 | 4733 | 3.38 |
| Carbon-carbon lyase activity (MF) | 2 | 173 | 3.82 |
| Carbohydrate transport (BP) | 2 | 170 | 3.82 |
| Organic acid catabolic process (MF) | 2 | 191 | 4.18 |
| Carboxylic acid catabolic process (MF) | 2 | 191 | 4.18 |
| Transporter activity (MF) | 6 | 2526 | 4.18 |
a BP: Biological Process, CC: Cellular Component, MF: Molecular Function; b False discovery rate (cutoff <0.05).